Treatment of infant colic
AssigneeSociete des Produits Nestle S.A.
InventorsClara Lucia Garcia-Rodenas, Gabriela Bergonzelli Degonda
Life of this patent
Estimating the term…
Abstract
Methods and uses of B. longum strain ATCC-999 for the treatment or prophylaxis of infant colic are disclosed.
Claims21
A method for the treatment or prophylaxis of infant colic comprising administering a composition comprising Bifidobacterium longum ATCC BAA-999 to an infant in need of same.
A method for reducing cerebral activity in an infant with colic comprising administering a composition comprising Bifidobacterium longum ATCC BAA-999 to an infant in need of same.
(canceled)
A method of reducing frequency and/or duration of episodes of irritability, fussing and/or crying in a subject with infant colic, comprising administering Bifidobacterium longum ATCC BAA-999 or a composition thereof to the infant.
8-12. (canceled)
15-16. (canceled)
Dependencies are inferred from the claim text.